Gastroenterology · Long Beach, CA
NPI
1285641233
Since 2006
Specialty
Gastroenterology
Code 174400000X
Group practices
1
Medicare group memberships
Hospitals
2
Hospital affiliations
3833 Worsham Avenue, Suite 300
Long Beach, CA, 90808
Phone (562) 595-5421
Groups this clinician bills Medicare through
Medicare paid, 2024
$111K
1,001 services
Medicare patients, 2024
644
Average age 73
Drug cost, 2024
$951K
1,832 prescriptions
Company payments, 2025
$2,453
From 17 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Kalpana Patel was code 99213 (office e&m - established), 170 times for 153 patients. In total Kalpana Patel billed 1,001 services in 26 codes, and Medicare paid $111K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2022-01-10.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99213 Office E&M - Established | Office | 170 | 153 | $65.29 | $11K |
| 99214 Office E&M - Established | Office | 161 | 133 | $93.98 | $15K |
| 45385 Colonoscopy - Lesion Removal | Facility | 138 | 138 | $197.48 | $27K |
| 43239 Upper GI Endoscopy | Facility | 118 | 115 | $86.66 | $10K |
| 45380 Lower GI Endoscopy - Other | Facility | 106 | 106 | $93.23 | $9,883 |
| 99204 Office E&M - New | Office | 59 | 59 | $137.85 | $8,133 |
| 99203 Office E&M - New | Office | 48 | 48 | $70.87 | $3,402 |
| 99202 Office E&M - New | Office | 44 | 44 | $51.57 | $2,269 |
| G0121 Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | Facility | 35 | 35 | $186.12 | $6,514 |
| G0105 Colorectal cancer screening; colonoscopy on individual at high risk | Facility | 27 | 27 | $188.41 | $5,087 |
| 45378 Lower GI Endoscopy - Other | Facility | 20 | 20 | $151.37 | $3,027 |
| 76700 Ultrasound - Abdomen and Pelvis | Office | 16 | 15 | $85.00 | $1,360 |
| 99212 Office E&M - Established | Office | 15 | 15 | $36.83 | $552 |
By year: 2022 $111K for 1,065 services; 2023 $108K for 961 services; 2024 $111K for 1,001 services.
Medicare prescription drug claims, 2024
In 2024, the drug Kalpana Patel prescribed most often to Medicare patients was Pantoprazole Sodium, with 428 prescriptions and refills. In total Kalpana Patel wrote 1,832 Medicare prescriptions that cost $951K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Pantoprazole Sodium Generic | 428 | 836 | 136 | $4,864 |
| Famotidine Generic | 328 | 676 | 106 | $3,201 |
| Omeprazole Generic | 274 | 498 | 71 | $2,875 |
| Sod Sulf-Potass Sulf-Mag Sulf Sodium, Potassium,mag Sulfates | 154 | 154 | 151 | $9,737 |
| Mesalamine Generic | 55 | 109 | Under 11 | $46K |
| Dicyclomine Hcl Generic | 44 | 61 | 25 | $568 |
| Xifaxan Rifaximin | 39 | 39 | 14 | $110K |
| Linzess Linaclotide | 39 | 60 | 11 | $31K |
| Humira(Cf) Pen Adalimumab | 29 | 35 | Under 11 | $249K |
| Trulance Plecanatide | 28 | 46 | Under 11 | $25K |
| Mercaptopurine Generic | 26 | 36 | Under 11 | $1,681 |
| Lubiprostone Generic | 23 | 31 | Under 11 | $2,493 |
| Dexlansoprazole Dr Dexlansoprazole | 22 | 40 | Under 11 | $6,100 |
| Sucralfate Generic | 21 | 23 | Under 11 | $3,234 |
| Amitriptyline Hcl Generic | 21 | 37 | Under 11 | $151 |
Brand drugs: - claims; generic drugs: 1,540 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Kalpana Patel $2,453 ($2,453 in general payments such as food, travel and fees) from 17 companies. The largest payer was Abbvie Inc. with $502.
| Company | Payments | Amount |
|---|---|---|
| Abbvie Inc. ABBV | 26 | $502 |
| Madrigal Pharmaceuticals MDGL | 14 | $476 |
| Janssen Biotech, Inc. JNJ | 17 | $451 |
| Genzyme Corporation SNY | 3 | $200 |
| Pfizer Inc. PFE | 7 | $162 |
| Phathom Pharmaceuticals, Inc. PHAT | 7 | $152 |
| Aimmune Therapeutics, Inc. | 6 | $140 |
| CapsoVision, Inc. CV | 2 | $80.79 |
| Regeneron Healthcare Solutions, Inc. REGN | 3 | $75.25 |
| Ardelyx, Inc. ARDX | 2 | $41.07 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.